Don Healey
CIK: 0001643067
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Adicet Bio, Inc.
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Mar 25, 2026ACET
Adicet Bio, Inc.
Award(A)DirectStock Option (Right to Buy)
43.4K shares- - Jan 24, 2026ACET
Adicet Bio, Inc.
Tax Payment(F)Direct535 shares at avg. $8.44$5K - Jan 31, 2025ACET
Adicet Bio, Inc.
Award(A)DirectStock Option (Right to Buy)
275K shares- - Jan 24, 2025ACET
Adicet Bio, Inc.
Tax Payment(F)Direct8.6K shares at avg. $0.92$8K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Mar 25, 2026 | ACET Adicet Bio, Inc. | Award(A) Stock Option (Right to Buy) | 43,361 | - | - | Direct |
| Jan 24, 2026 | ACET Adicet Bio, Inc. | Tax Payment(F) | 535 | $8.44 | $4,515 | Direct |
| Jan 31, 2025 | ACET Adicet Bio, Inc. | Award(A) Stock Option (Right to Buy) | 275,000 | - | - | Direct |
| Jan 24, 2025 | ACET Adicet Bio, Inc. | Tax Payment(F) | 8,560 | $0.92 | $7,891 | Direct |
1-4 of 4 transactions
About Healey Don
Healey Don (SEC CIK 0001643067) files insider reports with the SEC as Chief Technology Officer of Adicet Bio, Inc. (ACET).
Signal8 holds 4 ownership filings by Healey Don, all Form 4s, filed between Jan 28, 2025 and Mar 27, 2026. Those filings report 4 transactions, from Jan 24, 2025 to Mar 25, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Healey Don's filings is in BOSTON, MA.
Recent filings by Healey Don
Other insiders filing for Adicet Bio, Inc. (ACET)
- Klickstein Lloyd, Chief Medical Officer
- Schor Chen, President & CEO
- Aftab Blake, Chief Scientific Officer
- DUBIN STEVE, Director
- Chodakewitz Jeffrey, Director
- Grissinger Michael, Director